RxDoctor Payments Data

Jennifer Leibovitch, MD

Hematology-Oncology · Syracuse, NYNPI 1740714864

Payments from drug & device makers

What this record shows

This record is dominated by education: $85 of the $85 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Sanofi-aventis U.S. LLC.

$85in general payments, 2019–2025

Across 1 payment — averaging $84.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$85

What the payments were for

  • Education$85100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi-aventis U.S. LLC1$85

How this compares

$85 in reported general payments places this provider in the 55th percentile of 38 hematology-oncology providers in New York.

See all hematology-oncology providers in New York

Medicare billing

Part B allowed, 2024
$599,416
Medicare patients
176
Services billed
23,174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Abiraterone Acetate15$46,842
EliquisApixaban45$33,878
XareltoRivaroxaban12$6,400
Anastrozole70$2,142
Tamoxifen Citrate14$341
Hydroxyurea17$339
Prednisone18$55

Paid to pharmacies, not to this prescriber.

Other hematology-oncology in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →